Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Arthritis, Rheumatoid × Hydroxychloroquine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 10 Breast Neoplasms 7 Prostatic Neoplasms 6 Colorectal Neoplasms 6 Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Multiple Myeloma 3 Melanoma 3 Gastrointestinal Neoplasms 3 COVID-19 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Solid Tumor 2 Recurrence 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Leukemia 2 Glioblastoma 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Renal Cell 2 Adenocarcinoma of Lung 2 Urologic Diseases 1 Untreated Resectable Pancreatic Adenocarcinoma 1 Sarcoma, Clear Cell 1 Sarcoma 1 Respiratory Distress Syndrome 1 Resectable Localized Prostate Cancer 1

Interventions

Etanercept 16 Adalimumab 16 Methotrexate 10 Infliximab 8 tocilizumab 7 golimumab 6 Rituximab 6 tofacitinib 5 Abatacept 5 Tumor Necrosis Factor Inhibitors 4 Certolizumab Pegol 4 olokizumab 3 Saline Solution 2 RC-18 2 Nivolumab 2 Leflunomide 2 Antirheumatic Agents 2 veltuzumab 1 upadacitinib 1 secukinumab 1 sarilumab 1 mavrilimumab 1 entecavir 1 baricitinib 1 andecaliximab 1 Vitamin D 1 Vaccines 1 Syringes 1 Surveys and Questionnaires 1 Sulfasalazine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03449758 2022-04-28

SariPRO

Sanofi

Phase 4 Completed

84 enrolled 36 charts

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡